Recursion to Participate in Upcoming Investor Conferences is drawing significant interest across the industry.
Salt Lake City, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →